All In Biotech

Drug Trial Radar · NCT06846528

A Study to Investigate the Pharmacokinetics of AZD2389 When Administered Alone and in Combination With Itraconazole in Healthy Participants

An Open-label, Fixed Sequence Study in Healthy Participants to Assess the Pharmacokinetics of AZD2389 When Administered Alone and in Combination With Itraconazole

Last checked: Nov 19, 2026Latest source record: Apr 29, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

16

Actual

Start

Feb 26, 2025

Primary completion

Apr 23, 2025

Study completion Apr 23, 2025

Sponsor

Lead sponsor
AstraZenecaAstraZeneca (AZN)
Sponsor type
Industry
Collaborators
Parexel
First posted
Feb 26, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the pharmacokinetics (PK) of AZD2389 when administered alone and in combination with itraconazole in healthy participants.

Conditions

  • Healthy Participants

Interventions

  • AZD2389Drug

    AZD2389 is administered orally

  • ItraconazoleDrug

    Itraconazole is administered orally

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Maximum observed drug concentration (Cmax) of AZD2389Time frame: Day 1 to Day 8
  2. Area under concentration-timecurve from time zero to infinity (AUCinf) of AZD2389Time frame: Day 1 to Day 8
  3. Area under concentration-curve from time 0 to the last quantifiable concentration (AUClast) of AZD2389Time frame: Day 1 to Day 8

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Research Site

    Brooklyn, Maryland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.